Dr. Theophile Tuyisabe is one of only 18 ophthalmologists in Rwanda. We spoke with him about how he does it.
Explaining Chagas disease through the stories of patients in Latin America.
AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.
Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
A collaboration in Ghana aims to expand early diagnosis and treatment of people with this inherited illness.
The most lethal strain could be eliminated by 2030, but major hurdles remain.
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
This site is intended for a global audience.